Objective-To determine if neutrophils from blood and synovial fluid of patients with rheumatoid arthritis and other joint arthropathies express interleukin-1l mRNA. Methods-RNA was isolated from neutrophils from patient and control blood, and synovial fluid ofpatients, probed in northern blots, and quantified by densitometry.
In rheumatoid arthritis, the normally acellular joint fluid is infiltrated by a variety of immune cells, including T and B lymphocytes, mononuclear phagocytes, and neutrophils.' During active disease, most of the infiltrating leucocytes are neutrophils and these have been activated in situ to release toxic reactive oxidants and granule enzymes.2 3 Rheumatoid synovial fluid contains many cytokines which may be produced by mononuclear phagocytes and endothelial cells. However, it is known also that neutrophils can secrete a variety of cyto- kines,"5 the amounts secreted being generally between five and 10-fold less (on a cell basis) than levels produced by mononuclear phagocytes. Nevertheless, because neutrophils can infiltrate tissues in vast numbers, neutrophil derived cytokines are pathophysiologically important.
We have investigated whether neutrophils contribute to interleukin-l expression in rheumatoid disease. This cytokine is present in high concentrations within diseased joints and is implicated in disease pathology. 9 10 It has been shown that a variety of proinflammatory mediators induce transient expression of this cytokine in human neutrophils.8" A recent investigation of interleukin-l ,B expression by rheumatoid neutrophils failed to detect ex vivo protein secretion in synovial cells, but the protein was detected in some blood neutrophils from rheumatoid patients. 2 We have measured interleukin-1,B mRNA in blood and synovial fluid neutrophils from patients with a variety of joint arthropathies.
Materials and methods

PATIENTS
We studied 26 patients attending the rheumatology clinics at the Royal Liverpool University Hospital, all with classical or seropositive rheumatoid arthritis (American Rheumatism Association criteria). Others examined were: two patients with seronegative polyarthritis, two with ankylosing spondylitis, one with Lyme's disease, and one with psoriatic arthritis. All were receiving non-steroidal anti-inflammatory drugs and none received steroids within the previous six months. PREPARATION 
OF NEUTROPHIS
Neutrophils were isolated from buffy coats by sedimentation in dextran/Ficoll-Hypaque, as described previously.'3 Neutrophils were also isolated from the blood and synovial fluid of patients with rheumatoid arthritis and other joint arthropathies as described previously.2 3 After purification, cells were suspended in RPMI 1640 medium and counted using a Fuchs-Rosenthal haemocytometer. Cell purity and viability were routinely assessed by Wright's staining and Trypan Blue exclusion and found to be > 97% and > 90%, respectively, for all preparations.
RNA EXTRACTION
Neutrophils from buffy coats were incubated at 107 cells/ml in RPMI 1640 with or without 50 U/ml granulocyte macrophage colony stimulating factor (GM-CSF) at 37°C for periods of up to 24 hours. After incubation for 1, 2, 4 and 24 hours, samples were removed for isolation of RNA. RNA was also extracted from patient or control blood neutrophils and patient synovial fluid neutrophils immediately after isolation. Cell pellets were suspended in 4 molll guanidinium isothiocyanate, /5% ,B-mercaptoethanol, 50 mmol/l EDTA, 50 mmol/l Tris, pH 7-0, and lysed by being drawn through a 23 gauge needle to shear chromosomal DNA. The suspension was layered onto a caesium chloride (CsCl)/EDTA gradient (5 7 mol/l CsCl, Interleukin-1 expression by neutrophils in rheumatoid arthritis 50 mmol/l EDTA, density= 1-3995 ± 0-001) and centrifuged at 100 000 g for 16 hours at 14°C. The RNA pellet was suspended in diethylpyrocarbonate (DEPC) treated water and precipitated overnight with 0-3 moVl sodium acetate and 2-5 vol ethanol at -80°C. The RNA was quantified by ultraviolet spectroscopy (typically 2 ,ug RNA/I07 neutrophils) and stored in 10 ,ug aliquots at -80°C as ethanol precipitates.
NORTHERN BLOTS
Aliquots of RNA (10 ,ug) were subjected to electrophoresis on 1-2% agarose gels (containing 1% (v/v) formaldehyde, 20 mmoYl 3-N-morpholinopropane sulphonic acid, 1 mmoll EDTA, 5 mmol/l sodium acetate, pH 8-0) for 16 hours at 5 mA. The gels were then stained in ethidium bromide and RNA was visualised by ultraviolet illumination. The RNA was then transferred by capillary blotting onto Zetaprobe GT nylon membrane (BioRad) in 20 x salt/sodium citrate (SSC) (3 mol/l NaCl, 0-3 mol/l sodium citrate, pH 7-0). Filters were baked at 80°C for 30 minutes, stored at room temperature in Saranwrap until use and then probed with labelled inserts prepared from the following cDNA clones obtained from the American Type Culture Collection (ATCC): interleukin-l,B (ATCC 67024); v-fins (ATCC 41016); ,B-actin (ATCC 65128). The cDNA inserts were excised using appropriate restriction endonucleases and isolated from vector DNA by electrophoresis in low melting point agarose. Each insert (50-100 ng) was radiolabelled by random primed labelling using 25 ,uCi
[32P]-cytidine triphosphate (CTP) for 20 hours at 16°C. Unincorporated [32P]-CTP was removed from the labelled cDNA using Nuctrap columns (Stratagene). Radioactivity incorporated was typically > 108 cpm/,ug DNA. The filters were prehybridised for 30 minutes at 65°C in 0-25 mol/l Na2HPO4-7H20/7% sodium dodecyl sulphate (SDS), pH 7-2, and then hybridised with the probe for 16-20 hours in the same buffer at 65°C. Filters were washed in 20 mmol/l Na2HPO4-7H20/5% SDS, pH 7-2, twice for 30 minutes at 65°C, followed by two 10 minute washes in 20 mmolll Na2HPO4-7H20/0-1% SDS at the same temperature. They were then blotted dry, wrapped in Saranwrap and exposed to x ray film (Fuji RX) for 24-48 hours. After autoradiography, probes were removed by heating the filters to 95°C in 0-1 x SSC containing 0-5% SDS, twice for 20 minutes. After autoradiographic confirmation of removal ofthe probe, the filters were reprobed.
(Little Chalfont, UK), and rGM-CSF was from Glaxo (Greenford, UK). The last was a non-glycosylated peptide with an activity of .1-5 mU/mg in the AML-193 proliferation assay. All other reagents were of the highest purity available.
Results
Addition of 50 U/ml GM-CSF to normal blood neutrophils for one hour induced a large increase in mRNA levels for interleukin-1(3 (fig lA-C, lane 1) . However, in mRNA of synovial fluid neutrophils from 21 patients with rheumatoid arthritis, transcripts for interleukin-1, were present at low, but detectable levels (fig lA-C, lanes 2-7) , being 0-1-2% of levels maximally induced by exposure of control blood neutrophils (from healthy donors) to GM-CSF in vitro. To obtain the results shown in this figure, the filters were exposed to film for seven days in order to visualise these low hybridisation signals. Similar levels of mRNA for interleukin-1 ,B were detected in neutrophils from the synovial fluid of two patients with seronegative polyarthritis, but none was detected in neutrophils from two patients with ankylosing spondylitis, one with Lyme's disease or one with psoriatic arthritis (data not shown).
When the filters were stripped and probed for v-fns mRNA (the macrophage colony stimulating factor receptor), no hybridisation signals were detected (data not shown), thus 1 Figure 2 shows northern blots of blood neutrophils from five patients, together with the paired synovial fluid neutrophil samples, from filters exposed to film for two days to develop the interleukin-1 signal. In two patients with seronegative arthritis and two patients with ankylosing spondylitis, the hybridisation signals for interleukin-1[3 mRNA in the blood neutrophils were undetectable (data not shown).
Discussion
Much evidence indicates that neutrophils contribute to the cytokine cascade during inflammation. Previous work has shown that mRNA for interleukin-1 is not expressed in S.. Figure 2 Interleukin-1f3 expression in blood and sy nov ial fluid neutrophils fromn patienits zwith rheumatoid arthritis. Patient RNA analysed and quantified on blots that also contained RNA from conitrol blood neutrophils treated with GM-CSF in vitro. After probinggfor interleukmi-1,3 18nRNA (filters exposed to filmtz for two days), filters were stripped and probed for actin mRINA. A: LAN\FE 1, conitrol blood neutrophils; i-AN'E 2, control blood tneutrophils inlcubated for one hour with 50 U/ml GM-CSF; z.\-1 3, blood neutrophils from patient 1; e1-.\E 4, svnovialfluid nieutrophils from2 patient 1; Li \F 5, blood nieuitrophils froml patient 2; iLAN\-E 6, synovialfluid neutrophils fromti patient 2; LA.\'P 7, blood neutrophils fromn patient 3; Li.\'1i 8, synovial fluid neutrophilsfromn patient 3. B: L4.\-i-1, conitrol blood neutrophils; I-AvE 2, conttrol blood neutrophils incubatedJfor one hour with 50 U/nil GM-CSF; i-A. \E 
